Professional Documents
Culture Documents
Drug Study Eclampsia City Hospital
Drug Study Eclampsia City Hospital
Drug Study Eclampsia City Hospital
RESPONSIBILITIES
Magnesium Sulfate
Classification: > Depresses CNS, > MgSO4 is indicated Concentrations CNS: Weakness, Before:
Antacid, blocks peripheral for immediate - Allergy to drowsiness, > Monitor knee-jerk
anticonvulsant, neuromuscular control of life- magnesium products dizziness, fainting, reflex.
electrolyte, laxative. transmission, threatening - Myocardial damage sweating > Monitor respiratory
produces convulsions in the - 2hr preceding rate.
Dosage: anticonvulsant treatment of severe delivery Respiratory: > Monitor urine
> 5 gms IVP as stat effects; decreases toxemias (pre- Decreased output.
dose amount of eclampsia and Precaution respiratory rate
> 5 gms deep IM acetylcholine eclampsia) of - Renal insufficiency During:
each buttocks as stat released at end-plate pregnancy. CV: Palpitations > Observe 12 R’s in
dose by motor nerve giving meds
impulse. Metabolic: > Assess for injection
> Prevention of Magnesium site
seizures in severe intoxication, > Give IM route by
preeclampsia hypocalcemia with deep IM injection.
tetany.
After:
> Monitor urine
output
> Monitor respiratory
rate or breathing
difficulties
> Report sweating,
flushing, muscle
tremors or twitching,
inability to move
extremities.
> Maintain urine
output at a level of
<30 mL every 1hr
DRUG ACTION INDICATION CONTRAINDICATION ADVERSE EFFECT NURSING
RESPONSIBILITIES
Hydralazine